06826

Shanghai Haohai Biological Techn…

23.35

-0.35-1.48%

Closed16:08 05/13 HKT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE23.700/23.700

TODAY RANGE23.350-23.800

VOL294.00K

MARKET CAP5.45B

52 WEEK RANGE21.700-46.000

AVG VOL (3M)605.62K

% TURNOVER0.13%

TURNOVER6.93M

P/E (TTM)12.160

% RANGE1.90%

EPS(TTM)1.920

P/E(FORWARD)8.879

P/B0.886

BVPS26.343

DIVIDEND1.076

P/S1.525

BETA--

DIV YIELD4.61%

FREE FLOAT MKT CAP913.96M

SHARES OUTSTANDING233.19M

NEXT EARNINGS08/14-08/18

FREE FLOAT39.14M

LOT SIZE100

EX-DIV DATE06/17/2025

News

Press Releases

Financial Reports

Profile

Simply Wall St·04/28 22:55
Shanghai Haohai Biological Technology First Quarter 2025 Earnings: EPS: CN¥0.39 (vs CN¥0.42 in 1Q 2024)
Reuters·04/25 13:45
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY Q1 REVENUE RMB 618.5 MILLION
Simply Wall St·03/30 22:06
Asian Undervalued Small Caps With Insider Buying To Watch
Simply Wall St·03/19 23:06
These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Safely
Reuters·02/19 12:07
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY FY REVENUE RMB 2,698 MILLION
Simply Wall St·02/10 23:02
Undiscovered Gems on None for February 2025
Simply Wall St·12/02/2024 17:04
Undiscovered Gems with Strong Fundamentals to Explore This December 2024
Simply Wall St·11/18/2024 03:29
The recent HK$611m market cap decrease is likely to have disappointed insiders invested in Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Simply Wall St·10/28/2024 00:42
Shanghai Haohai Biological Technology Third Quarter 2024 Earnings: EPS: CN¥2.19 (vs CN¥0.36 in 3Q 2023)
Reuters·10/25/2024 11:19
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY Q3 REVENUE RMB 670.4 MILLION
Simply Wall St·09/30/2024 06:50
While shareholders of Shanghai Haohai Biological Technology (HKG:6826) are in the red over the last three years, underlying earnings have actually grown
Simply Wall St·08/30/2024 22:40
Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Simply Wall St·07/25/2024 02:11
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Simply Wall St·06/24/2024 22:37
Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) top holders are insiders and they are likely disappointed by the recent 9.2% drop
Simply Wall St·05/22/2024 22:28
Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All

Same Industry

Name/Symbol

Change%

Price

Shanghai Haohai Biological Technology

06826

-1.48%

23.350

Angelalign Technology

06699

-2.01%

53.700

China Isotope & Radiation

01763

-0.34%

11.620

Shandong Weigao Group Medical Polymer

02981

12.180

Beijing Chunlizhengda Medical Instruments

01858

+4.64%

9.700

Shanghai INT Medical Instruments

01501

+0.96%

26.400

Shandong Weigao Group Medical Polymer

01066

-1.31%

6.010

Shanghai Conant Optical

02276

-0.39%

25.750

Kangji Medical Holdings

09997

+1.50%

7.430

Arts Optical International Holdings

01120

0.00%

1.060

Acotec Scientific Holdings

06669

0.00%

7.870

Modern Dental Group

03600

-1.93%

4.060

Ak Medical Holdings

01789

+2.48%

5.780

OrbusNeich Medical Group Holdings

06929

-1.57%

3.750

Austar Lifesciences

06118

-5.06%

0.750

South China Assets Holdings

08155

0.00%

0.011

IVD Medical Holding

01931

0.00%

1.590

PW Medtech Group

01358

-0.93%

1.060

Biosino Bio-Technology and Science Incorporation

08247

0.00%

0.610

Kelfred Holdings

01134

-0.53%

0.186

Grand Brilliance Group Holdings

08372

0.00%

0.124

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.